ArticleMethods in molecular biology (Clifton, N.J.)2026
Automated Analysis of Liquid Biopsy Using Deep Learning: Detecting Circulating Tumor Cells and Cancer-Associated Fibroblasts.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cell detection is one of the most significant tasks in circulating tumor cells (CTCs) and cancer-associated fibroblasts (CAFs) analysis, as these cells are emerging as potential biomarkers for cancer prognosis and diagnosis. Traditional approaches to cell detection are often manual, leading to long turnaround times and significant variability between experts. In this chapter, we first provide an overview of deep learning techniques for general cell detection, with a specific focus on CTC and CAF detection. We then discuss developments in optical imaging systems that offer high-resolution, high-quality, and all-in-focus imaging capabilities. By integrating advanced optical hardware with deep learning algorithms, we demonstrate high-accuracy and high-fidelity detection of CTCs and CAFs in microfiltered-based samples. We also emphasize the need for refined technologies and models to enhance the clinical utility of CTC characterization and deepen the understanding of metastasis. The integrated approach introduced in this chapter has the potential to establish a new automated paradigm for CTC and CAF analysis.
Indexed as
Identifiers
42426467What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.